Title : Revolutionizing neurodegenerative disease management through phytochemical-based neuroprotection
Abstract:
Neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other age-associated cognitive disorders, represent one of the greatest global health challenges due to increasing life expectancy and the absence of curative therapies. Progressive neuronal loss, oxidative stress, chronic neuroinflammation, mitochondrial dysfunction, protein misfolding, excitotoxicity, impaired autophagy, and blood–brain barrier dysfunction collectively contribute to disease onset and progression. Current pharmacological interventions are primarily symptomatic and offer limited efficacy in preventing neuronal degeneration or restoring cognitive function, highlighting the urgent need for safe, multitarget therapeutic strategies. Phytochemicals, a diverse group of bioactive compounds derived from medicinal plants and functional foods, have emerged as promising neuroprotective agents capable of simultaneously modulating multiple pathogenic pathways involved in neurodegeneration. Polyphenols, flavonoids, carotenoids, alkaloids, terpenoids, and organosulfur compounds exert potent antioxidant, anti-inflammatory, anti-apoptotic, and mitochondrial protective effects while regulating cellular signaling networks such as Nrf2/ARE, NF-κB, PI3K/Akt, MAPK, AMPK, SIRT1, and BDNF/CREB. Furthermore, many phytochemicals attenuate amyloid-β aggregation, inhibit tau hyperphosphorylation, reduce α-synuclein toxicity, enhance autophagic clearance of misfolded proteins, improve synaptic plasticity, and preserve neuronal integrity. Emerging evidence also suggests that phytochemicals influence the gut–brain axis, modulate neuroimmune responses, and improve metabolic homeostasis, thereby providing broader protection against age-related cognitive decline. Recent advances in phytotechnology, including nan formulations, phytosome-based delivery systems, liposomes, and polymeric nanoparticles, have significantly improved the bioavailability, stability, and blood–brain barrier penetration of phytochemicals, facilitating their translational potential. Integrating phytochemicals with precision nutrition, nutraceuticals, and personalized medicine offers new opportunities for preventive and adjunctive management of neurodegenerative diseases. This presentation highlights the molecular mechanisms underlying phytochemical-mediated neuroprotection, summarizes current preclinical and clinical evidence, discusses innovative delivery strategies, and explores future directions for translating plant-derived bioactives into effective interventions for healthy brain aging. Harnessing the multitarget therapeutic potential of phytochemicals may revolutionize brain health by promoting resilience against neurodegeneration, delaying cognitive decline, and improving quality of life in aging populations.
Keywords: Phytochemicals; Neuroprotection; Neurodegeneration; Brain Aging; Dementia; Alzheimer's Disease; Parkinson's Disease; Mitochondrial Dysfunction; Gut–Brain Axis

